Royalty Pharma plc
Royalty Pharma plc (RPRX) Covered Calls
As of September 25, 2026, RPRX has 10 covered call opportunities in the coming three months. Return ranges from 3.2 to 20.4% until expiration. Annualized return ranges from 10.2 to 56.4%. The nearest expiration is October 16, 2026. Maximum potential profit is $1,189.
Read more
Running RPRX covered calls helps you generate consistent income from Royalty Pharma plc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Royalty Pharma plc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best RPRX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if RPRX stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling RPRX covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Royalty Pharma plc covered call is worth writing.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes.
The company was founded in 1996 and is based in New York, New York.
Income-focused investors, long-term RPRX holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling RPRX covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Royalty Pharma plc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile16.67% Subdued
- Market cap (M$)33,474
- 52 weeks high-9.58%
- 52 weeks low68.09%
- Analyst recommendationStrong Buy
1.50 - Target price$65.71
11.97% above the current stock price - Dividend—
- Payout ratio49.40%
- Earnings date2026-11-04
- P/E30.99
- Future P/E10.15
- EPS (ttm)1.88
- EPS growth next 5 years10.23%
As of September 25, 2026
| 2026-10-16 | 21 | 60.00 | 3.08 | 0.10 | 1.00 | 189.00 | 3.25 | 56.43 | -0.17 | +0.30 | 204 | 0.90 |
| 2027-01-15 | 112 | 65.00 | 11.66 | 0.10 | 4.80 | 689.00 | 11.84 | 38.57 | -0.17 | +0.35 | 53 | 4.70 |
| 2027-04-16 | 203 | 70.00 | 20.25 | 0.10 | 4.90 | 1189.00 | 20.43 | 36.73 | -0.17 | +0.30 | 11 | 4.80 |
| 2027-04-16 | 203 | 67.50 | 15.96 | 0.15 | 4.90 | 944.00 | 16.22 | 29.16 | -0.26 | +0.33 | 15 | 4.75 |
| 2027-01-15 | 112 | 62.50 | 7.37 | 0.40 | 4.90 | 469.00 | 8.06 | 26.26 | -0.69 | +0.40 | 20 | 4.50 |
| 2026-11-20 | 56 | 60.00 | 3.08 | 0.20 | 4.90 | 199.00 | 3.42 | 22.28 | -0.34 | +0.46 | 3 | 4.70 |
| 2026-12-18 | 84 | 60.00 | 3.08 | 0.50 | 4.90 | 229.00 | 3.93 | 17.09 | -0.86 | +0.47 | 92 | 4.40 |
| 2027-04-16 | 203 | 62.50 | 7.37 | 0.70 | 5.50 | 499.00 | 8.57 | 15.41 | -1.20 | +0.43 | 1 | 4.80 |
| 2027-01-15 | 112 | 60.00 | 3.08 | 0.80 | 4.90 | 259.00 | 4.45 | 14.50 | -1.37 | +0.48 | 200 | 4.10 |
| 2027-04-16 | 203 | 60.00 | 3.08 | 1.50 | 6.30 | 329.00 | 5.65 | 10.16 | -2.58 | +0.52 | 24 | 4.80 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best RPRX covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→